1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Organ and Tissue Transplantation and Alternative Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Organ and Tissue Transplantation and Alternative by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Organ and Tissue Transplantation and Alternative by Country/Region, 2018, 2022 & 2029
2.2 Organ and Tissue Transplantation and Alternative Segment by Type
2.2.1 Organ Transplantation
2.2.2 Tissue Transplantation
2.2.3 Cell Transplantation
2.3 Organ and Tissue Transplantation and Alternative Sales by Type
2.3.1 Global Organ and Tissue Transplantation and Alternative Sales Market Share by Type (2018-2023)
2.3.2 Global Organ and Tissue Transplantation and Alternative Revenue and Market Share by Type (2018-2023)
2.3.3 Global Organ and Tissue Transplantation and Alternative Sale Price by Type (2018-2023)
2.4 Organ and Tissue Transplantation and Alternative Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Laboratory
2.5 Organ and Tissue Transplantation and Alternative Sales by Application
2.5.1 Global Organ and Tissue Transplantation and Alternative Sale Market Share by Application (2018-2023)
2.5.2 Global Organ and Tissue Transplantation and Alternative Revenue and Market Share by Application (2018-2023)
2.5.3 Global Organ and Tissue Transplantation and Alternative Sale Price by Application (2018-2023)
3 Global Organ and Tissue Transplantation and Alternative by Company
3.1 Global Organ and Tissue Transplantation and Alternative Breakdown Data by Company
3.1.1 Global Organ and Tissue Transplantation and Alternative Annual Sales by Company (2018-2023)
3.1.2 Global Organ and Tissue Transplantation and Alternative Sales Market Share by Company (2018-2023)
3.2 Global Organ and Tissue Transplantation and Alternative Annual Revenue by Company (2018-2023)
3.2.1 Global Organ and Tissue Transplantation and Alternative Revenue by Company (2018-2023)
3.2.2 Global Organ and Tissue Transplantation and Alternative Revenue Market Share by Company (2018-2023)
3.3 Global Organ and Tissue Transplantation and Alternative Sale Price by Company
3.4 Key Manufacturers Organ and Tissue Transplantation and Alternative Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Organ and Tissue Transplantation and Alternative Product Location Distribution
3.4.2 Players Organ and Tissue Transplantation and Alternative Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Organ and Tissue Transplantation and Alternative by Geographic Region
4.1 World Historic Organ and Tissue Transplantation and Alternative Market Size by Geographic Region (2018-2023)
4.1.1 Global Organ and Tissue Transplantation and Alternative Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Organ and Tissue Transplantation and Alternative Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Organ and Tissue Transplantation and Alternative Market Size by Country/Region (2018-2023)
4.2.1 Global Organ and Tissue Transplantation and Alternative Annual Sales by Country/Region (2018-2023)
4.2.2 Global Organ and Tissue Transplantation and Alternative Annual Revenue by Country/Region (2018-2023)
4.3 Americas Organ and Tissue Transplantation and Alternative Sales Growth
4.4 APAC Organ and Tissue Transplantation and Alternative Sales Growth
4.5 Europe Organ and Tissue Transplantation and Alternative Sales Growth
4.6 Middle East & Africa Organ and Tissue Transplantation and Alternative Sales Growth
5 Americas
5.1 Americas Organ and Tissue Transplantation and Alternative Sales by Country
5.1.1 Americas Organ and Tissue Transplantation and Alternative Sales by Country (2018-2023)
5.1.2 Americas Organ and Tissue Transplantation and Alternative Revenue by Country (2018-2023)
5.2 Americas Organ and Tissue Transplantation and Alternative Sales by Type
5.3 Americas Organ and Tissue Transplantation and Alternative Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Organ and Tissue Transplantation and Alternative Sales by Region
6.1.1 APAC Organ and Tissue Transplantation and Alternative Sales by Region (2018-2023)
6.1.2 APAC Organ and Tissue Transplantation and Alternative Revenue by Region (2018-2023)
6.2 APAC Organ and Tissue Transplantation and Alternative Sales by Type
6.3 APAC Organ and Tissue Transplantation and Alternative Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Organ and Tissue Transplantation and Alternative by Country
7.1.1 Europe Organ and Tissue Transplantation and Alternative Sales by Country (2018-2023)
7.1.2 Europe Organ and Tissue Transplantation and Alternative Revenue by Country (2018-2023)
7.2 Europe Organ and Tissue Transplantation and Alternative Sales by Type
7.3 Europe Organ and Tissue Transplantation and Alternative Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Organ and Tissue Transplantation and Alternative by Country
8.1.1 Middle East & Africa Organ and Tissue Transplantation and Alternative Sales by Country (2018-2023)
8.1.2 Middle East & Africa Organ and Tissue Transplantation and Alternative Revenue by Country (2018-2023)
8.2 Middle East & Africa Organ and Tissue Transplantation and Alternative Sales by Type
8.3 Middle East & Africa Organ and Tissue Transplantation and Alternative Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Organ and Tissue Transplantation and Alternative
10.3 Manufacturing Process Analysis of Organ and Tissue Transplantation and Alternative
10.4 Industry Chain Structure of Organ and Tissue Transplantation and Alternative
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Organ and Tissue Transplantation and Alternative Distributors
11.3 Organ and Tissue Transplantation and Alternative Customer
12 World Forecast Review for Organ and Tissue Transplantation and Alternative by Geographic Region
12.1 Global Organ and Tissue Transplantation and Alternative Market Size Forecast by Region
12.1.1 Global Organ and Tissue Transplantation and Alternative Forecast by Region (2024-2029)
12.1.2 Global Organ and Tissue Transplantation and Alternative Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Organ and Tissue Transplantation and Alternative Forecast by Type
12.7 Global Organ and Tissue Transplantation and Alternative Forecast by Application
13 Key Players Analysis
13.1 Abbott
13.1.1 Abbott Company Information
13.1.2 Abbott Organ and Tissue Transplantation and Alternative Product Portfolios and Specifications
13.1.3 Abbott Organ and Tissue Transplantation and Alternative Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Abbott Main Business Overview
13.1.5 Abbott Latest Developments
13.2 Arthrex
13.2.1 Arthrex Company Information
13.2.2 Arthrex Organ and Tissue Transplantation and Alternative Product Portfolios and Specifications
13.2.3 Arthrex Organ and Tissue Transplantation and Alternative Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Arthrex Main Business Overview
13.2.5 Arthrex Latest Developments
13.3 Biomet
13.3.1 Biomet Company Information
13.3.2 Biomet Organ and Tissue Transplantation and Alternative Product Portfolios and Specifications
13.3.3 Biomet Organ and Tissue Transplantation and Alternative Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Biomet Main Business Overview
13.3.5 Biomet Latest Developments
13.4 Bristol-Myers
13.4.1 Bristol-Myers Company Information
13.4.2 Bristol-Myers Organ and Tissue Transplantation and Alternative Product Portfolios and Specifications
13.4.3 Bristol-Myers Organ and Tissue Transplantation and Alternative Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Bristol-Myers Main Business Overview
13.4.5 Bristol-Myers Latest Developments
13.5 Centacor
13.5.1 Centacor Company Information
13.5.2 Centacor Organ and Tissue Transplantation and Alternative Product Portfolios and Specifications
13.5.3 Centacor Organ and Tissue Transplantation and Alternative Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Centacor Main Business Overview
13.5.5 Centacor Latest Developments
13.6 CryoLife, Inc.
13.6.1 CryoLife, Inc. Company Information
13.6.2 CryoLife, Inc. Organ and Tissue Transplantation and Alternative Product Portfolios and Specifications
13.6.3 CryoLife, Inc. Organ and Tissue Transplantation and Alternative Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 CryoLife, Inc. Main Business Overview
13.6.5 CryoLife, Inc. Latest Developments
13.7 Dr. Franz Köhler Chemie GmbH
13.7.1 Dr. Franz Köhler Chemie GmbH Company Information
13.7.2 Dr. Franz Köhler Chemie GmbH Organ and Tissue Transplantation and Alternative Product Portfolios and Specifications
13.7.3 Dr. Franz Köhler Chemie GmbH Organ and Tissue Transplantation and Alternative Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Dr. Franz Köhler Chemie GmbH Main Business Overview
13.7.5 Dr. Franz Köhler Chemie GmbH Latest Developments
13.8 Novartis
13.8.1 Novartis Company Information
13.8.2 Novartis Organ and Tissue Transplantation and Alternative Product Portfolios and Specifications
13.8.3 Novartis Organ and Tissue Transplantation and Alternative Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Novartis Main Business Overview
13.8.5 Novartis Latest Developments
13.9 Organ Transport Systems
13.9.1 Organ Transport Systems Company Information
13.9.2 Organ Transport Systems Organ and Tissue Transplantation and Alternative Product Portfolios and Specifications
13.9.3 Organ Transport Systems Organ and Tissue Transplantation and Alternative Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Organ Transport Systems Main Business Overview
13.9.5 Organ Transport Systems Latest Developments
13.10 Organogenesis, Inc.
13.10.1 Organogenesis, Inc. Company Information
13.10.2 Organogenesis, Inc. Organ and Tissue Transplantation and Alternative Product Portfolios and Specifications
13.10.3 Organogenesis, Inc. Organ and Tissue Transplantation and Alternative Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Organogenesis, Inc. Main Business Overview
13.10.5 Organogenesis, Inc. Latest Developments
13.11 XVIVO Perfusion AB
13.11.1 XVIVO Perfusion AB Company Information
13.11.2 XVIVO Perfusion AB Organ and Tissue Transplantation and Alternative Product Portfolios and Specifications
13.11.3 XVIVO Perfusion AB Organ and Tissue Transplantation and Alternative Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 XVIVO Perfusion AB Main Business Overview
13.11.5 XVIVO Perfusion AB Latest Developments
14 Research Findings and Conclusion
Table 1. Organ and Tissue Transplantation and Alternative Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Organ and Tissue Transplantation and Alternative Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Organ Transplantation
Table 4. Major Players of Tissue Transplantation
Table 5. Major Players of Cell Transplantation
Table 6. Global Organ and Tissue Transplantation and Alternative Sales by Type (2018-2023) & (K Units)
Table 7. Global Organ and Tissue Transplantation and Alternative Sales Market Share by Type (2018-2023)
Table 8. Global Organ and Tissue Transplantation and Alternative Revenue by Type (2018-2023) & ($ million)
Table 9. Global Organ and Tissue Transplantation and Alternative Revenue Market Share by Type (2018-2023)
Table 10. Global Organ and Tissue Transplantation and Alternative Sale Price by Type (2018-2023) & (US$/Unit)
Table 11. Global Organ and Tissue Transplantation and Alternative Sales by Application (2018-2023) & (K Units)
Table 12. Global Organ and Tissue Transplantation and Alternative Sales Market Share by Application (2018-2023)
Table 13. Global Organ and Tissue Transplantation and Alternative Revenue by Application (2018-2023)
Table 14. Global Organ and Tissue Transplantation and Alternative Revenue Market Share by Application (2018-2023)
Table 15. Global Organ and Tissue Transplantation and Alternative Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global Organ and Tissue Transplantation and Alternative Sales by Company (2018-2023) & (K Units)
Table 17. Global Organ and Tissue Transplantation and Alternative Sales Market Share by Company (2018-2023)
Table 18. Global Organ and Tissue Transplantation and Alternative Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Organ and Tissue Transplantation and Alternative Revenue Market Share by Company (2018-2023)
Table 20. Global Organ and Tissue Transplantation and Alternative Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers Organ and Tissue Transplantation and Alternative Producing Area Distribution and Sales Area
Table 22. Players Organ and Tissue Transplantation and Alternative Products Offered
Table 23. Organ and Tissue Transplantation and Alternative Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Organ and Tissue Transplantation and Alternative Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Organ and Tissue Transplantation and Alternative Sales Market Share Geographic Region (2018-2023)
Table 28. Global Organ and Tissue Transplantation and Alternative Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Organ and Tissue Transplantation and Alternative Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Organ and Tissue Transplantation and Alternative Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Organ and Tissue Transplantation and Alternative Sales Market Share by Country/Region (2018-2023)
Table 32. Global Organ and Tissue Transplantation and Alternative Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Organ and Tissue Transplantation and Alternative Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Organ and Tissue Transplantation and Alternative Sales by Country (2018-2023) & (K Units)
Table 35. Americas Organ and Tissue Transplantation and Alternative Sales Market Share by Country (2018-2023)
Table 36. Americas Organ and Tissue Transplantation and Alternative Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Organ and Tissue Transplantation and Alternative Revenue Market Share by Country (2018-2023)
Table 38. Americas Organ and Tissue Transplantation and Alternative Sales by Type (2018-2023) & (K Units)
Table 39. Americas Organ and Tissue Transplantation and Alternative Sales by Application (2018-2023) & (K Units)
Table 40. APAC Organ and Tissue Transplantation and Alternative Sales by Region (2018-2023) & (K Units)
Table 41. APAC Organ and Tissue Transplantation and Alternative Sales Market Share by Region (2018-2023)
Table 42. APAC Organ and Tissue Transplantation and Alternative Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Organ and Tissue Transplantation and Alternative Revenue Market Share by Region (2018-2023)
Table 44. APAC Organ and Tissue Transplantation and Alternative Sales by Type (2018-2023) & (K Units)
Table 45. APAC Organ and Tissue Transplantation and Alternative Sales by Application (2018-2023) & (K Units)
Table 46. Europe Organ and Tissue Transplantation and Alternative Sales by Country (2018-2023) & (K Units)
Table 47. Europe Organ and Tissue Transplantation and Alternative Sales Market Share by Country (2018-2023)
Table 48. Europe Organ and Tissue Transplantation and Alternative Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Organ and Tissue Transplantation and Alternative Revenue Market Share by Country (2018-2023)
Table 50. Europe Organ and Tissue Transplantation and Alternative Sales by Type (2018-2023) & (K Units)
Table 51. Europe Organ and Tissue Transplantation and Alternative Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Organ and Tissue Transplantation and Alternative Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Organ and Tissue Transplantation and Alternative Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Organ and Tissue Transplantation and Alternative Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Organ and Tissue Transplantation and Alternative Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Organ and Tissue Transplantation and Alternative Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Organ and Tissue Transplantation and Alternative Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Organ and Tissue Transplantation and Alternative
Table 59. Key Market Challenges & Risks of Organ and Tissue Transplantation and Alternative
Table 60. Key Industry Trends of Organ and Tissue Transplantation and Alternative
Table 61. Organ and Tissue Transplantation and Alternative Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Organ and Tissue Transplantation and Alternative Distributors List
Table 64. Organ and Tissue Transplantation and Alternative Customer List
Table 65. Global Organ and Tissue Transplantation and Alternative Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Organ and Tissue Transplantation and Alternative Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Organ and Tissue Transplantation and Alternative Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Organ and Tissue Transplantation and Alternative Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Organ and Tissue Transplantation and Alternative Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Organ and Tissue Transplantation and Alternative Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Organ and Tissue Transplantation and Alternative Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Organ and Tissue Transplantation and Alternative Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Organ and Tissue Transplantation and Alternative Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Organ and Tissue Transplantation and Alternative Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Organ and Tissue Transplantation and Alternative Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Organ and Tissue Transplantation and Alternative Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Organ and Tissue Transplantation and Alternative Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Organ and Tissue Transplantation and Alternative Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Abbott Basic Information, Organ and Tissue Transplantation and Alternative Manufacturing Base, Sales Area and Its Competitors
Table 80. Abbott Organ and Tissue Transplantation and Alternative Product Portfolios and Specifications
Table 81. Abbott Organ and Tissue Transplantation and Alternative Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. Abbott Main Business
Table 83. Abbott Latest Developments
Table 84. Arthrex Basic Information, Organ and Tissue Transplantation and Alternative Manufacturing Base, Sales Area and Its Competitors
Table 85. Arthrex Organ and Tissue Transplantation and Alternative Product Portfolios and Specifications
Table 86. Arthrex Organ and Tissue Transplantation and Alternative Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. Arthrex Main Business
Table 88. Arthrex Latest Developments
Table 89. Biomet Basic Information, Organ and Tissue Transplantation and Alternative Manufacturing Base, Sales Area and Its Competitors
Table 90. Biomet Organ and Tissue Transplantation and Alternative Product Portfolios and Specifications
Table 91. Biomet Organ and Tissue Transplantation and Alternative Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. Biomet Main Business
Table 93. Biomet Latest Developments
Table 94. Bristol-Myers Basic Information, Organ and Tissue Transplantation and Alternative Manufacturing Base, Sales Area and Its Competitors
Table 95. Bristol-Myers Organ and Tissue Transplantation and Alternative Product Portfolios and Specifications
Table 96. Bristol-Myers Organ and Tissue Transplantation and Alternative Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. Bristol-Myers Main Business
Table 98. Bristol-Myers Latest Developments
Table 99. Centacor Basic Information, Organ and Tissue Transplantation and Alternative Manufacturing Base, Sales Area and Its Competitors
Table 100. Centacor Organ and Tissue Transplantation and Alternative Product Portfolios and Specifications
Table 101. Centacor Organ and Tissue Transplantation and Alternative Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. Centacor Main Business
Table 103. Centacor Latest Developments
Table 104. CryoLife, Inc. Basic Information, Organ and Tissue Transplantation and Alternative Manufacturing Base, Sales Area and Its Competitors
Table 105. CryoLife, Inc. Organ and Tissue Transplantation and Alternative Product Portfolios and Specifications
Table 106. CryoLife, Inc. Organ and Tissue Transplantation and Alternative Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. CryoLife, Inc. Main Business
Table 108. CryoLife, Inc. Latest Developments
Table 109. Dr. Franz Köhler Chemie GmbH Basic Information, Organ and Tissue Transplantation and Alternative Manufacturing Base, Sales Area and Its Competitors
Table 110. Dr. Franz Köhler Chemie GmbH Organ and Tissue Transplantation and Alternative Product Portfolios and Specifications
Table 111. Dr. Franz Köhler Chemie GmbH Organ and Tissue Transplantation and Alternative Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. Dr. Franz Köhler Chemie GmbH Main Business
Table 113. Dr. Franz Köhler Chemie GmbH Latest Developments
Table 114. Novartis Basic Information, Organ and Tissue Transplantation and Alternative Manufacturing Base, Sales Area and Its Competitors
Table 115. Novartis Organ and Tissue Transplantation and Alternative Product Portfolios and Specifications
Table 116. Novartis Organ and Tissue Transplantation and Alternative Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. Novartis Main Business
Table 118. Novartis Latest Developments
Table 119. Organ Transport Systems Basic Information, Organ and Tissue Transplantation and Alternative Manufacturing Base, Sales Area and Its Competitors
Table 120. Organ Transport Systems Organ and Tissue Transplantation and Alternative Product Portfolios and Specifications
Table 121. Organ Transport Systems Organ and Tissue Transplantation and Alternative Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. Organ Transport Systems Main Business
Table 123. Organ Transport Systems Latest Developments
Table 124. Organogenesis, Inc. Basic Information, Organ and Tissue Transplantation and Alternative Manufacturing Base, Sales Area and Its Competitors
Table 125. Organogenesis, Inc. Organ and Tissue Transplantation and Alternative Product Portfolios and Specifications
Table 126. Organogenesis, Inc. Organ and Tissue Transplantation and Alternative Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 127. Organogenesis, Inc. Main Business
Table 128. Organogenesis, Inc. Latest Developments
Table 129. XVIVO Perfusion AB Basic Information, Organ and Tissue Transplantation and Alternative Manufacturing Base, Sales Area and Its Competitors
Table 130. XVIVO Perfusion AB Organ and Tissue Transplantation and Alternative Product Portfolios and Specifications
Table 131. XVIVO Perfusion AB Organ and Tissue Transplantation and Alternative Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 132. XVIVO Perfusion AB Main Business
Table 133. XVIVO Perfusion AB Latest Developments
List of Figures
Figure 1. Picture of Organ and Tissue Transplantation and Alternative
Figure 2. Organ and Tissue Transplantation and Alternative Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Organ and Tissue Transplantation and Alternative Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Organ and Tissue Transplantation and Alternative Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Organ and Tissue Transplantation and Alternative Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Organ Transplantation
Figure 10. Product Picture of Tissue Transplantation
Figure 11. Product Picture of Cell Transplantation
Figure 12. Global Organ and Tissue Transplantation and Alternative Sales Market Share by Type in 2022
Figure 13. Global Organ and Tissue Transplantation and Alternative Revenue Market Share by Type (2018-2023)
Figure 14. Organ and Tissue Transplantation and Alternative Consumed in Hospital
Figure 15. Global Organ and Tissue Transplantation and Alternative Market: Hospital (2018-2023) & (K Units)
Figure 16. Organ and Tissue Transplantation and Alternative Consumed in Clinic
Figure 17. Global Organ and Tissue Transplantation and Alternative Market: Clinic (2018-2023) & (K Units)
Figure 18. Organ and Tissue Transplantation and Alternative Consumed in Laboratory
Figure 19. Global Organ and Tissue Transplantation and Alternative Market: Laboratory (2018-2023) & (K Units)
Figure 20. Global Organ and Tissue Transplantation and Alternative Sales Market Share by Application (2022)
Figure 21. Global Organ and Tissue Transplantation and Alternative Revenue Market Share by Application in 2022
Figure 22. Organ and Tissue Transplantation and Alternative Sales Market by Company in 2022 (K Units)
Figure 23. Global Organ and Tissue Transplantation and Alternative Sales Market Share by Company in 2022
Figure 24. Organ and Tissue Transplantation and Alternative Revenue Market by Company in 2022 ($ Million)
Figure 25. Global Organ and Tissue Transplantation and Alternative Revenue Market Share by Company in 2022
Figure 26. Global Organ and Tissue Transplantation and Alternative Sales Market Share by Geographic Region (2018-2023)
Figure 27. Global Organ and Tissue Transplantation and Alternative Revenue Market Share by Geographic Region in 2022
Figure 28. Americas Organ and Tissue Transplantation and Alternative Sales 2018-2023 (K Units)
Figure 29. Americas Organ and Tissue Transplantation and Alternative Revenue 2018-2023 ($ Millions)
Figure 30. APAC Organ and Tissue Transplantation and Alternative Sales 2018-2023 (K Units)
Figure 31. APAC Organ and Tissue Transplantation and Alternative Revenue 2018-2023 ($ Millions)
Figure 32. Europe Organ and Tissue Transplantation and Alternative Sales 2018-2023 (K Units)
Figure 33. Europe Organ and Tissue Transplantation and Alternative Revenue 2018-2023 ($ Millions)
Figure 34. Middle East & Africa Organ and Tissue Transplantation and Alternative Sales 2018-2023 (K Units)
Figure 35. Middle East & Africa Organ and Tissue Transplantation and Alternative Revenue 2018-2023 ($ Millions)
Figure 36. Americas Organ and Tissue Transplantation and Alternative Sales Market Share by Country in 2022
Figure 37. Americas Organ and Tissue Transplantation and Alternative Revenue Market Share by Country in 2022
Figure 38. Americas Organ and Tissue Transplantation and Alternative Sales Market Share by Type (2018-2023)
Figure 39. Americas Organ and Tissue Transplantation and Alternative Sales Market Share by Application (2018-2023)
Figure 40. United States Organ and Tissue Transplantation and Alternative Revenue Growth 2018-2023 ($ Millions)
Figure 41. Canada Organ and Tissue Transplantation and Alternative Revenue Growth 2018-2023 ($ Millions)
Figure 42. Mexico Organ and Tissue Transplantation and Alternative Revenue Growth 2018-2023 ($ Millions)
Figure 43. Brazil Organ and Tissue Transplantation and Alternative Revenue Growth 2018-2023 ($ Millions)
Figure 44. APAC Organ and Tissue Transplantation and Alternative Sales Market Share by Region in 2022
Figure 45. APAC Organ and Tissue Transplantation and Alternative Revenue Market Share by Regions in 2022
Figure 46. APAC Organ and Tissue Transplantation and Alternative Sales Market Share by Type (2018-2023)
Figure 47. APAC Organ and Tissue Transplantation and Alternative Sales Market Share by Application (2018-2023)
Figure 48. China Organ and Tissue Transplantation and Alternative Revenue Growth 2018-2023 ($ Millions)
Figure 49. Japan Organ and Tissue Transplantation and Alternative Revenue Growth 2018-2023 ($ Millions)
Figure 50. South Korea Organ and Tissue Transplantation and Alternative Revenue Growth 2018-2023 ($ Millions)
Figure 51. Southeast Asia Organ and Tissue Transplantation and Alternative Revenue Growth 2018-2023 ($ Millions)
Figure 52. India Organ and Tissue Transplantation and Alternative Revenue Growth 2018-2023 ($ Millions)
Figure 53. Australia Organ and Tissue Transplantation and Alternative Revenue Growth 2018-2023 ($ Millions)
Figure 54. China Taiwan Organ and Tissue Transplantation and Alternative Revenue Growth 2018-2023 ($ Millions)
Figure 55. Europe Organ and Tissue Transplantation and Alternative Sales Market Share by Country in 2022
Figure 56. Europe Organ and Tissue Transplantation and Alternative Revenue Market Share by Country in 2022
Figure 57. Europe Organ and Tissue Transplantation and Alternative Sales Market Share by Type (2018-2023)
Figure 58. Europe Organ and Tissue Transplantation and Alternative Sales Market Share by Application (2018-2023)
Figure 59. Germany Organ and Tissue Transplantation and Alternative Revenue Growth 2018-2023 ($ Millions)
Figure 60. France Organ and Tissue Transplantation and Alternative Revenue Growth 2018-2023 ($ Millions)
Figure 61. UK Organ and Tissue Transplantation and Alternative Revenue Growth 2018-2023 ($ Millions)
Figure 62. Italy Organ and Tissue Transplantation and Alternative Revenue Growth 2018-2023 ($ Millions)
Figure 63. Russia Organ and Tissue Transplantation and Alternative Revenue Growth 2018-2023 ($ Millions)
Figure 64. Middle East & Africa Organ and Tissue Transplantation and Alternative Sales Market Share by Country in 2022
Figure 65. Middle East & Africa Organ and Tissue Transplantation and Alternative Revenue Market Share by Country in 2022
Figure 66. Middle East & Africa Organ and Tissue Transplantation and Alternative Sales Market Share by Type (2018-2023)
Figure 67. Middle East & Africa Organ and Tissue Transplantation and Alternative Sales Market Share by Application (2018-2023)
Figure 68. Egypt Organ and Tissue Transplantation and Alternative Revenue Growth 2018-2023 ($ Millions)
Figure 69. South Africa Organ and Tissue Transplantation and Alternative Revenue Growth 2018-2023 ($ Millions)
Figure 70. Israel Organ and Tissue Transplantation and Alternative Revenue Growth 2018-2023 ($ Millions)
Figure 71. Turkey Organ and Tissue Transplantation and Alternative Revenue Growth 2018-2023 ($ Millions)
Figure 72. GCC Country Organ and Tissue Transplantation and Alternative Revenue Growth 2018-2023 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Organ and Tissue Transplantation and Alternative in 2022
Figure 74. Manufacturing Process Analysis of Organ and Tissue Transplantation and Alternative
Figure 75. Industry Chain Structure of Organ and Tissue Transplantation and Alternative
Figure 76. Channels of Distribution
Figure 77. Global Organ and Tissue Transplantation and Alternative Sales Market Forecast by Region (2024-2029)
Figure 78. Global Organ and Tissue Transplantation and Alternative Revenue Market Share Forecast by Region (2024-2029)
Figure 79. Global Organ and Tissue Transplantation and Alternative Sales Market Share Forecast by Type (2024-2029)
Figure 80. Global Organ and Tissue Transplantation and Alternative Revenue Market Share Forecast by Type (2024-2029)
Figure 81. Global Organ and Tissue Transplantation and Alternative Sales Market Share Forecast by Application (2024-2029)
Figure 82. Global Organ and Tissue Transplantation and Alternative Revenue Market Share Forecast by Application (2024-2029)
| ※参考情報 臓器や組織の移植および代替品の概念は、医学の分野において重要な役割を果たしています。この分野は、様々な病気や障害に対する治療法として、多くの患者に希望を与えるものです。以下に、このテーマに関する基本的な定義、特徴、種類、用途、関連技術などを詳述いたします。 まず、臓器移植とは、病気や損傷によって機能が損なわれた臓器を、同様の機能を持つ健康な臓器に置き換える手術のことを指します。このプロセスは、通常、提供者から受け取った臓器を受け手に移植する形で行われます。組織移植は、同様の原理に基づいており、皮膚や筋肉、血管などの組織を移植することを意味します。 移植の特徴としては、まず、患者の生存率や生活の質の向上に寄与するという点が挙げられます。心臓や肝臓、腎臓など、重篤な疾患によって機能が失われた場合、移植によって新たな臓器を獲得することができ、その後の健康状態が大きく改善される可能性があります。また、移植は特定の病気や障害の根本的な治療法となることが多く、他の治療法に比べて長期的な効果が期待できる場合があります。 次に、臓器や組織の移植にはいくつかの種類があります。これには、自家移植、同種移植、異種移植の分類が含まれます。自家移植は、患者自身の別の部分から臓器や組織を移植する方法です。一方、同種移植は、他人から提供された臓器や組織を使用するもので、ドナーは生きている場合もあれば、亡くなった場合もあります。異種移植は、異なる種からの臓器や組織を使用する方法ですが、免疫反応や倫理的問題が伴うため、実用化は遅れている状況です。 用途についても、移植は多岐にわたります。腎臓移植は、慢性腎不全の治療において非常に一般的な方法です。肝臓移植は、肝硬変や肝臓の悪性腫瘍を有する患者に対して行われます。心臓移植は、重度の心不全など、心臓の機能が極度に低下した患者に対して行われます。このように、それぞれの臓器や組織には特定の適応症があり、患者の状況に応じて適切な治療法が選択されます。 移植における関連技術やプロセスも重要です。移植の成功には、適切なドナーの選定が不可欠であり、ドナーとレシピエント（受け手）の間の臓器適合性が重要な要素となります。この適合性は、主にHLA（ヒト白血球抗原）型の一致によって評価され、免疫拒絶反応を最小限に抑えるために考慮されます。 また、移植後の免疫抑制療法も重要です。レシピエントの体が移植された臓器を拒絶しないようにするため、抗免疫薬を使用することが一般的です。これにより、移植された臓器の生存率が向上し、患者の生活の質が維持されます。しかし、免疫抑制療法には感染症のリスクや悪性腫瘍の発生率が増加するなどの副作用があるため、注意が必要です。 さらに、臓器や組織移植の代替品に関しても触れたいと思います。生体材料や再生医療の進展により、移植を必要としない新しいアプローチが模索されています。人工臓器や生体適合性の素材を用いた組織工学などがその一例です。これらの技術は、患者の体内で機能するよう設計されており、拒絶反応のリスクを大幅に削減することが期待されています。 特に、幹細胞研究の進展は、組織再生の可能性を広げています。幹細胞から特定の細胞を誘導することで、損傷した組織や臓器を再生することができると考えられています。これにより、自身の細胞を使用した移植が可能になり、免疫抑制療法も不要になる可能性があります。 全体として、臓器や組織移植およびそれに関連する代替品の分野は、急速に進化していることがわかります。技術の進歩により、より多くの患者が救われる可能性がある一方で、倫理的な問題や医療資源の配分といった課題も残っています。今後の研究や実践により、この分野がより多くの人々に恩恵をもたらすことが期待されます。 |
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
